All research papers

Implementation of VMAT-based lattice spatially fractionated radiation therapy (SFRT) across linac platforms: Practical considerations for QA and motion management.

Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study.

Comparison of percutaneous and transarterial fiducial marker placement before proton therapy for pancreatic cancer.

Intra-respiratory variation in tumour-diaphragm geometric association as a potential surrogate for dynamic tumour-tracking radiotherapy.

Neoadjuvant Early Stereotactic Body Radiation Therapy Followed by Chemoimmunotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.

Impact of Bipyridine and Phenanthroline Incorporation into the Macropa Scaffold on Ba(II)/Ra(II) Chelation.

Experimental and simulated ${{{\mathrm{H}}}_2}{{{\mathrm{O}}}_2}$ in pure water under conventional and ultra-high dose rates for single pulse proton irradiation.

Personalized eye protection for head CT organ-based tube current modulation: A deep learning approach to derive 3D eyeball models from a single-view topogram.

Liver tumor motion and reconstructed doses in a clinical trial of respiratory gated proton therapy for hepatocellular carcinoma.

Hypofractionated Radiation Therapy for Breast Cancer: A Unit Review in Alignment with International Guidelines.

Learning From Target-Level Incomplete Annotation: A Novel Perspective for Weakly-Supervised Multi-Lesion Segmentation.

Clinically Generalizable Low-Dose CT Denoising for Pediatric Imaging via Enhanced Diffusion Posterior Sampling.

Advances in molecular imaging: diagnostic, technical, and therapeutic considerations-introductory Editorial.

Uncertainty quantification of U-Net based segmentation tool using conformal prediction.

Physics-informed patient-specific calibration for monocular visual-based dose reconstruction in breast cancer radiotherapy.

µPIU-Net: A Domain-Specific Sinogram Infilling U-Net for Micro-CBCT and the Limitations of Generalized Models

Synthetic CT-enabled weekly adaptive radiotherapy for nasopharyngeal carcinoma: Optimizing plan adaptation triggers through volumetric-dosimetric monitoring.

Deep learning-based dose prediction for MR-guided prostate SIB: Supporting rapid feasibility assessment and adaptive editing margin selection.

Blinded, bias-controlled multi-rater evaluation of human-versus-AI brain metastasis segmentation using a hybrid foundation-model framework.

An MRI Atlas of Regional Brain Vulnerability to Metastatic Disease

Clinical Outcomes of Ablative MR-Guided Adaptive SBRT for Pancreatic Lesions.

Dosimetry Analysis of ¹⁷⁷Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.

DHODH-Mediated Suppression of Ferroptosis Supports Radioresistance and Represents a Therapeutic Vulnerability in Lung Cancer.

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRT.

Method for simultaneous selection of treatment isocenters and margins for polymetastatic extracranial stereotactic ablative radiotherapy.

Dual-scan conformal cone-beam CT for targeted image-quality improvement using dynamic collimation.

Conditional sparing in FLASH radiotherapy: Conformal dosimetry and ALARA remain essential.

Explainable machine learning for patient-specific quality assurance in intensity-modulated radiotherapy based on anatomical structures.

Latent density discrepancies in commercial lung-equivalent inserts and their clinical dosimetric impact.

Multi-TPS institutional surveillance of VMAT plan complexity and PSQA results over three years.

A JavaScript-based computational method for predicting decay activity of 131I: development, benchmark- and phantom-based assessment of an open-access research tool.

Selpercatinib-induced Redifferentiation and Enhanced Radioiodine Uptake in Radioiodine-refractory Thyroid Cancer: A Case Report.

Phase 1 Dose-Escalation Study of [²²⁵Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry.

Atomic degradation: chemical design strategies and immunotherapeutic mechanisms of radio-PROTACs.

Circulating Tumor DNA Genomic Profiling in ²²³Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study.

Per-Lesion Assessment of Individual MRI Sequences and 68 Ga-DOTATATE PET in Neuroendocrine Liver Metastases.

⁶⁸GA DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis.

Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis.

Preparation of electroplated zinc-68 targets for gallium-68 cyclotron production using recovered zinc-68.

Clinical and research applications of fibroblast activation protein-α inhibitor tracers: a review.

Radiolabeled Angiopep-2 Peptide Vector as a Preclinical Platform for Blood-Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice.

Clinical performance of [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT in detecting recurrent disease in medullary thyroid carcinoma: a comparative analysis with [¹⁸F]F-FDG and [⁶⁸Ga]Ga-DOTATATE PET/CT, alongside identification of suitable candidates for targeted radionuclide therapy.

Evolving SPECT-CT technology.

Theranostics and molecular imaging are taking off: current situation, requirements and how to train more physicians to fill the gap. A perspective from three different continents.

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [¹⁷⁷Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics.

Targeted Radiation, Unintended Evolution.

Quantifying the Renal Impact of [¹⁷⁷Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry.

Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.

Improving image quality in terbium-161 phantom imaging: Quantitative evaluation of DEW and TEW scatter correction methods.

The Prognostic Value of ⁶⁸Ga-PSMA and ¹⁸F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with ¹⁷⁷Lu-EB-PSMA.

High-yield, standardised automated radiosynthesis process for routine clinical insulinoma PET with [⁶⁸Ga]Ga-NODAGA-exendin-4.

Effect of non-consecutive treatment during hypofractionated stereotactic radiosurgery (HF-SRS) for brain metastases.

Patient-specific quality assurance in stereotactic radiotherapy: clinical practice in absence of guidelines - status and new approach from the DGMP working group for physics and technology in stereotactic radiotherapy.

Comparative evaluation of ⁶⁷Ga production via the ⁶⁷Zn and ⁶⁸Zn routes on proton cyclotrons: Yield, radionuclidic purity, and cooling-time behavior.

A Mathematical Framework for Determining the Effect of Rotational Errors on Single-Isocenter Multi-target Stereotactic Radiosurgery.

A novel radionuclide probe targeting FN-EDB: a new strategy for radioactive iodine-refractory differentiated thyroid cancer.

Molecular plating for targetry: proof of concept using natGd(p,x)¹⁵⁵Tb cross section measurements.

99m Tc‑FAPI‑46 Scintigraphy for Staging of Non-Small Cell Lung Carcinoma.